BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
1. Why both groups will perform 5-weeks of exercise protocol? Is not clear why exercise protocol will finished in 5-weeks. Needs to justify.
2. The authors chose improves the power output to characterize a progression of overload. Why?
3. The authors need to be careful in randomization procedure, since the age of patients ranged of 18 to 75 years, which could mask some differences due to effects of biological aging process. 4. I suggest the inclusion of gait speed test due to relationship with mortality. View Studenski et al. 2011 . Gait speed and survival in older adults. JAMA. 5. The authors pointed that study will have two years of duration. Is not clear why, if the exercise training will have 5 weeks and only an evaluation post-training it is expected (figure 1). Please clarify.
6. Discussion. Why ECC exercise will be able to improve sixminutes walk test (your primary outcome)? Only due to improvement in knee extensor muscle strength? The authors hypothesize other central effects (e.g higher power output during exercise session compared to CON session)? The sample size is not understood, the principal outcome, 6MWT, is measured in meters and in the protocol is measured as distance gain. However in sample size it is reported as percentage change, expected difference and SD is not clear.
REVIEWER

VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
This study protocol will verify the impact of eccentric and concentric cycling rehab protocol on functionality, aerobic capacity and skeletal muscle parameters obtained through biopsy sample in chronic heart failure patients. The novelty and relevance of study is clear. Some questions needs to be reviewed to improve the quality of study protocol.
The training protocol duration was set at five weeks in both groups in order to match the standard duration of stay in French cardiac rehabilitation centers also enabling to meet the required 20 supervised exercise sessions for health insurance coverage by the French Health Care System. The 20 sessions duration has been approved by the Exercise Rehabilitation division of the French Cardiology Society as being sufficient to trigger achieve significant improvements in functional capacities (Pavy et al., 2011) . After this period, patients return home and are advised to continue to practice regular physical activity. The point of clarification is however well taken and the text was rewritten to clarify and justify the choice of five weeks (lines 177-179).
We chose to progressively increase intensity (i.e. power output) and duration of exercise session in order to reduce the occurrence of muscle damage and though the extent of muscle soreness associated with unaccustomed eccentric exercise. The sentence was slightly modified to be clearer about this concept (lines 220-222).
3. The authors need to be careful in randomization procedure, since the age of patients ranged of 18 to 75 years, which could mask some differences due to effects of biological aging process.
We thank the reviewer for this relevant point. We agree that with a wide range of ages, and without randomization on this parameter, we could miss out on or conversely observe significant differences that could be the result of biological aging process. However, patients usually referred to the rehabilitation center and meeting the all inclusion/exclusion criteria are more than 45 years old. Thus, the average age of the first seven patients included in the study is 68.4 ± 4.9 years. To take into account the reviewer's comment, we have revised the text to describe the protocol age range to 45-75 years old. We thank the reviewer for the suggestion. The gait speed test was included in the protocol (lines 295-302).
5. The authors pointed that study will have two years of duration. Is not clear why, if the exercise training will have 5 weeks and only an evaluation post-training it is expected ( figure 1) . Please clarify.
In re-reading the 'Study status' section, we understand the difficulty of understanding the sentence. Thus, the text has been modified to clearly establish that the recruitment period is two years to ensure that the intended number of participants are recruited but that the participation duration of each patient is five weeks (lines 372-375).
6. Discussion. Why ECC exercise will be able to improve six-minute walk test (your primary outcome)? Only due to improvement in knee extensor muscle strength? The authors hypothesize other central effects (e.g higher power output during exercise session compared to CON session)?
We acknowledge the various points of reflection presented by the reviewer and appreciate their pertinence. Indeed, we expect a greater improvement in muscle strength in the mixed group compared to the concentric group alone, mainly driven by eccentric exercise sessions. We are also expecting an improvement in peakVO2 parameters, as a result of central (i.e. cardiac and respiratory) and peripheral (muscular) parameters adaptations, by keeping concentric exercise sessions in this mixed group. Therefore, we think that the combination of eccentric and concentric could serve to potentiate the beneficial effects of each modality performed separately. The interest for the 6MWT lies in the fact that it can reflect both aerobic and strength gains translated into a functional assessment, comparable to activities of daily living.
Reviewer: 2
Very interesting protocol investigating an alternative purpose to train CHF.
Some little considerations:
-the authors should improve the introduction of the abstract, as it is quite unclear After reading the corresponding paragraph, we agree with the reviewer and thank her for her comment. The abstract introduction was rewritten to explain more clearly the context of the study (lines 41-46).
-is this protocol registered in trialgov or somewhere else? will be considered the use of CONSORT Checklist?
The protocol is registered in 'ClinicalTrials.gov' website under the trial registration number NCT03716778. As requested by the editorial board, we use the SPIRIT Checklist.
-English writing must be improved
Manuscript was edited and corrected by a native English speaker.
Reviewer: 3
No major questions. The protocol would gain some clarity if the following issues would be addressed:
-What was the rationale that led to the enrolment of patients with peak VO2 < 15, what about the others? Any external validity concerns if you restrict to this subset of HF patients?
We chose the 15 mL·min-1·kg-1 value for VO2 peak inclusion criteria because it is historically the upper limit value of the class C of Weber classification (Weber et al., 1982) . Although, we also made that choice according to the French High Authority of Health, which establishes that these patients most benefit from the exercise rehabilitation. Finally, through this protocol we really want to target NYHA class III patients for whom there are limitations in performing regular daily activities. The reviewer's comment is very relevant and we agree that it would be of interest in another instance to reproduce the study by extending it to other subsets of heart failure patients.
-If the patients are going to perform a maximal CPET, why did they choose as primary endpoint a 6MWT?
When patients are very limited, the exercise test on cycle-ergometer can be very short and limited by symptoms. It may not be very discriminating in NYHA stage III patients. However, the 6MWT is considered another simple, safe and inexpensive method to assess an integrated cardiopulmonary functional capacity (Guyatt et al., 1985) . It is also of interest as it may be seen to reflect both aerobic and strength capacities, especially in deconditioned patients.
-Why are the authors stratifying the randomization according to ischemic etiology?
We chose to stratify according to the presence or absence of ischemia because eccentric exercise can have an impact on vascular resistance (Meyer et al., 2003) , a parameter that is often affected by chronic heart failure. We therefore wished to isolate this potential effect in adaptive responses to training.
Reviewer: 4
It must be better justified what is the reason for the main outcome (6MWT) cannot be blind for distance evaluator.
We agree with the reviewer comment, for a greater scientific rigor and to limit potential bias, it would be necessary that a blind evaluator implements the 6MWT, like all the tests carried out during this protocol. However, the tests must be performed by experienced and trained staff, which is the case in the rehabilitation center. In addition, the intervention of a person outside the cardiopulmonary clinic would raise logistical and financial problems. However, the 6MWT is considered as a simple, safe and inexpensive method to assess an integrated cardiopulmonary functional capacity (Guyatt et al., 1985) .
It is also of interest as it may be seen to reflect both aerobic and strength capacities.
It should be better explained how allocation concealment will be guaranteed.
No part of the study will be blinded. We simply wanted to indicate that the allocation will only be made once the patient has been included in the study (i.e. with validity of the inclusion/exclusion criteria, and that the signed informed consent has been received) and a patient code has been assigned to him, this in order to avoid any selection bias This has been clarified (lines 410-413).
Survival analysis should be better explained. It is not understood what the event will be and what the censorship of this analysis.
As described in submitted manuscript, a particular attention will be paid to patients opting out of the study and therefore lost to follow-up. The reasons that could lead to the exclusion of a patient are multiple (i.e. non-compliance to protocol; unexpected health issue or hospitalization; etc.). To study how many patients stop the study and to take into account the time when they will dropped out, it was proposed to consider this event as a censored data and to present it using Kaplan-Meier approach (lines 449-452).
The sample size is not understood, the principal outcome, 6MWT, is measured in meters and in the protocol is measured as distance gain. However in sample size it is reported as percentage change, expected difference and SD is not clear.
We agree that some clarification may be needed. The primary endpoint is the change in the 6MWT, it will be expressed relative to the pre-rehabilitation distance and reported as percentage of change. Previous studies such as the cardiac rehabilitation study by Meyer et al. (1997) reported an expected distance gain of 35m on 6MWT which was equivalent to a 5 percent change. The sample size estimation was calculated here using a minimal absolute difference fixed at 3% (for a standard deviation expected between 2% and 4%), therefore it is more conservative. The manuscript was revised accordingly (lines 235-237).
